New York State Common Retirement Fund’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-160,597
| Closed | -$8.47M | – | 3324 |
|
|
2026
Q1 | $8.47M | Buy |
160,597
+95,294
| +146% | +$3.91M | 0.01% | 799 |
|
|
2025
Q4 | $2.64M | Buy |
65,303
+47,732
| +272% | +$1.1M | ﹤0.01% | 1294 |
|
|
2025
Q3 | $132K | Hold |
17,571
| – | – | ﹤0.01% | 2484 |
|
|
2025
Q2 | $65.5K | Hold |
17,571
| – | – | ﹤0.01% | 2863 |
|
|
2025
Q1 | $48.5K | Hold |
17,571
| – | – | ﹤0.01% | 2788 |
|
|
2024
Q4 | $97.3K | Hold |
17,571
| – | – | ﹤0.01% | 2601 |
|
|
2024
Q3 | $147K | Hold |
17,571
| – | – | ﹤0.01% | 2431 |
|
|
2024
Q2 | $120K | Hold |
17,571
| – | – | ﹤0.01% | 2658 |
|
|
2024
Q1 | $115K | Buy |
17,571
+7
| +0% | +$46 | ﹤0.01% | 2680 |
|
|
2023
Q4 | $114K | Sell |
17,564
-76
| -0.4% | -$402 | ﹤0.01% | 2699 |
|
|
2023
Q3 | $88.7K | Buy |
17,640
+440
| +3% | +$2.79K | ﹤0.01% | 2786 |
|
|
2023
Q2 | $151K | Buy |
+17,200
| New | +$200K | ﹤0.01% | 2624 |
|
|
2022
Q3 | – | Sell |
-118
| Closed | – | – | 3442 |
|
|
2022
Q2 | $0 | Sell |
118
-5,800
| -98% | -$11.6K | ﹤0.01% | 3539 |
|
|
2022
Q1 | $18K | Hold |
5,918
| – | – | ﹤0.01% | 3294 |
|
|
2021
Q4 | $42K | Buy |
5,918
+44
| +0.7% | +$366 | ﹤0.01% | 3252 |
|
|
2021
Q3 | $61K | Buy |
5,874
+5
| +0.1% | +$52 | ﹤0.01% | 3224 |
|
|
2021
Q2 | $72K | Buy |
5,869
+1,969
| +50% | +$33.5K | ﹤0.01% | 3246 |
|
|
2021
Q1 | $86K | Buy |
+3,900
| New | +$85.5K | ﹤0.01% | 3109 |
|
Other funds holding TERN
New York State Common Retirement Fund's TERN Position: Q2 2026 in Review
New York State Common Retirement Fund sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 160,597 shares — an estimated $8.47M sold.
New York State Common Retirement Fund first reported a position in TERN in Q1 2021 and held it in 18 quarters. The position peaked at $8.47M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.
- New York State Common Retirement Fund reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- New York State Common Retirement Fund sold 160,597 Terns Pharmaceuticals shares in Q2 2026, an estimated $8.47M.
- New York State Common Retirement Fund first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 18 quarters.
- New York State Common Retirement Fund's Terns Pharmaceuticals position peaked at $8.47M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.